• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

恶唑衍生物生物活性的综合综述。

A comprehensive review on biological activities of oxazole derivatives.

作者信息

Kakkar Saloni, Narasimhan Balasubramanian

机构信息

Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001 India.

出版信息

BMC Chem. 2019 Feb 4;13(1):16. doi: 10.1186/s13065-019-0531-9. eCollection 2019 Dec.

DOI:10.1186/s13065-019-0531-9
PMID:31384765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6661760/
Abstract

The utility of oxazole as intermediates for the synthesis of new chemical entities in medicinal chemistry have been increased in the past few years. Oxazole is an important heterocyclic nucleus having a wide spectrum of biological activities which drew the attention of researchers round the globe to synthesize various oxazole derivatives and screen them for their various biological activities. The present review article aims to review the work reported on therapeutic potentials of oxazole scaffolds which are valuable for medical applications during new millennium.

摘要

在过去几年中，恶唑作为药物化学中合成新化学实体的中间体的效用有所增加。恶唑是一种重要的杂环核，具有广泛的生物活性，这吸引了全球研究人员合成各种恶唑衍生物并对其各种生物活性进行筛选。本综述文章旨在回顾关于恶唑支架治疗潜力的报道工作，这些工作在新千年对医学应用具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/2106adaee329/13065_2019_531_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/19a2e68dcd27/13065_2019_531_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/5cd97f14a066/13065_2019_531_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/53828423071a/13065_2019_531_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/47a343312d51/13065_2019_531_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/c80805372e20/13065_2019_531_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/8cdc890af2e1/13065_2019_531_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/dc4054ebcc14/13065_2019_531_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/bb8d9b6befcd/13065_2019_531_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/b2f2a5a84da7/13065_2019_531_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/54755e3ee648/13065_2019_531_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/2106adaee329/13065_2019_531_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/19a2e68dcd27/13065_2019_531_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/5cd97f14a066/13065_2019_531_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/53828423071a/13065_2019_531_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/47a343312d51/13065_2019_531_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/c80805372e20/13065_2019_531_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/8cdc890af2e1/13065_2019_531_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/dc4054ebcc14/13065_2019_531_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/bb8d9b6befcd/13065_2019_531_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/b2f2a5a84da7/13065_2019_531_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/54755e3ee648/13065_2019_531_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608b/6661760/2106adaee329/13065_2019_531_Fig11_HTML.jpg

相似文献

1
A comprehensive review on biological activities of oxazole derivatives.恶唑衍生物生物活性的综合综述。
BMC Chem. 2019 Feb 4;13(1):16. doi: 10.1186/s13065-019-0531-9. eCollection 2019 Dec.
2
Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis.基于范吕森噁唑合成法的噁唑类分子合成的最新进展。
Molecules. 2020 Mar 31;25(7):1594. doi: 10.3390/molecules25071594.
3
Evaluation of 2,3-dihydroimidazo[2,1-]oxazole and imidazo[2,1-]oxazole derivatives as chemotherapeutic agents.评价 2,3-二氢咪唑并[2,1-]噁唑和咪唑并[2,1-]噁唑衍生物作为化疗药物。
Future Med Chem. 2023 Oct;15(20):1885-1901. doi: 10.4155/fmc-2023-0147. Epub 2023 Oct 10.
4
Recent advance in oxazole-based medicinal chemistry.基于恶唑的药物化学的最新进展。
Eur J Med Chem. 2018 Jan 20;144:444-492. doi: 10.1016/j.ejmech.2017.12.044. Epub 2017 Dec 14.
5
Therapeutic potential of oxazole scaffold: a patent review (2006-2017).唑类支架的治疗潜力：专利研究综述（2006-2017）。
Expert Opin Ther Pat. 2018 Nov;28(11):783-812. doi: 10.1080/13543776.2018.1526280. Epub 2018 Sep 26.
6
Therapeutic potential of heterocyclic pyrimidine scaffolds.杂环嘧啶支架的治疗潜力。
Chem Cent J. 2018 Apr 4;12(1):38. doi: 10.1186/s13065-018-0406-5.
7
Natural and synthetic 5-(3'-indolyl)oxazoles: Biological activity, chemical synthesis and advanced molecules.天然和合成的5-（3'-吲哚基）恶唑：生物活性、化学合成及高级分子
Med Res Rev. 2025 Jan;45(1):97-143. doi: 10.1002/med.22078. Epub 2024 Aug 16.
8
An Overview of Bioactive 1,3-Oxazole-Containing Alkaloids from Marine Organisms.海洋生物中含1,3-恶唑的生物活性生物碱概述
Pharmaceuticals (Basel). 2021 Dec 6;14(12):1274. doi: 10.3390/ph14121274.
9
A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles.苯并噻唑类化合物合成及药物治疗潜力的最新进展综述
Antiinflamm Antiallergy Agents Med Chem. 2015;14(2):98-112. doi: 10.2174/1871523014666150528110703.
10
Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2H-chromen-2-one derivatives.3-(2-氨基恶唑-5-基)-2H-色烯-2-酮衍生物的设计、合成及生物学评价
Chem Cent J. 2018 Dec 4;12(1):130. doi: 10.1186/s13065-018-0499-x.

引用本文的文献

1
The Green and Effective Synthesis of Isoxazole-Based Molecules Under Ultrasonic Irradiation Approaches.超声辐照下基于异恶唑分子的绿色高效合成方法
Pharmaceuticals (Basel). 2025 Aug 10;18(8):1179. doi: 10.3390/ph18081179.
2
Therapeutic Potential of Isoxazole-(Iso)oxazole Hybrids: Three Decades of Research.异恶唑-（异）恶唑杂化物的治疗潜力：三十年研究历程
Int J Mol Sci. 2025 Jul 23;26(15):7082. doi: 10.3390/ijms26157082.
3
Unraveling non-target screening variability for LC-HRMS data: a chemometric comparative analysis of river water samples impacted by treated wastewater.

本文引用的文献

1
Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2H-chromen-2-one derivatives.3-(2-氨基恶唑-5-基)-2H-色烯-2-酮衍生物的设计、合成及生物学评价
Chem Cent J. 2018 Dec 4;12(1):130. doi: 10.1186/s13065-018-0499-x.
2
Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.氧杂稠合萘酰亚胺类化合物作为抗肿瘤剂：合成与生物评价。
Eur J Med Chem. 2013 Apr;62:130-8. doi: 10.1016/j.ejmech.2012.12.039. Epub 2013 Jan 3.
3
Synthesis, bioassay, crystal structure and ab initio studies of Erlenmeyer azlactones.
解析液相色谱-高分辨质谱数据的非目标筛查变异性：受处理后废水影响的河水样本的化学计量学比较分析
Anal Bioanal Chem. 2025 Jun 25. doi: 10.1007/s00216-025-05966-1.
4
Crystal structure and Hirshfeld-surface analysis of the pesticide etoxazole.农药乙螨唑的晶体结构与 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2025 Feb 18;81(Pt 3):239-242. doi: 10.1107/S2056989025001173. eCollection 2025 Mar 1.
5
Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureas.杀锥虫的2-[(苯基杂芳基)乙基]脲类中的杂环核心修饰
RSC Med Chem. 2025 Jan 15. doi: 10.1039/d4md00764f.
6
Crystal structure and Hirshfeld-surface analysis of an etoxazole metabolite designated R13.一种名为R13的乙螨唑代谢物的晶体结构与 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2024 Nov 8;80(Pt 12):1270-1273. doi: 10.1107/S2056989024010600. eCollection 2024 Nov 1.
7
Multicomponent reactions (MCRs) yielding medicinally relevant rings: a recent update and chemical space analysis of the scaffolds.生成具有药物相关性环的多组分反应（MCRs）：支架的最新进展与化学空间分析
RSC Adv. 2025 Jan 16;15(2):1447-1489. doi: 10.1039/d4ra06681b. eCollection 2025 Jan 9.
8
Synthesis of Oxazoles Containing CF-Substituted Alcohol Unit via Tandem Cycloisomerization/Hydroxyalkylation from -Propargylamides with Trifluoropyruvates.通过串联环异构化/羟基烷基化反应，由-炔丙基酰胺与三氟丙酮酸酯合成含CF-取代醇单元的恶唑类化合物。
Molecules. 2024 Dec 11;29(24):5848. doi: 10.3390/molecules29245848.
9
Pyrazole derivatives as antileishmanial agents: Biological evaluation, molecular docking study, DFT analysis and ADME prediction.吡唑衍生物作为抗利什曼原虫剂：生物学评价、分子对接研究、密度泛函理论分析及药物代谢动力学预测
Heliyon. 2024 Nov 19;10(23):e40444. doi: 10.1016/j.heliyon.2024.e40444. eCollection 2024 Dec 15.
10
Antibacterial Activity and Antifungal Activity of Monomeric Alkaloids.单体生物碱的抗菌活性和抗真菌活性。
Toxins (Basel). 2024 Nov 12;16(11):489. doi: 10.3390/toxins16110489.
埃尔伦梅耶尔氮杂环戊酮的合成、生物测定、晶体结构和从头算研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Mar;104:538-45. doi: 10.1016/j.saa.2012.11.054. Epub 2012 Dec 5.
4
New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agents.新型恶唑桥连的康普瑞他汀A-4类似物作为潜在的血管破坏剂
Int J Clin Pharmacol Ther. 2013 Jan;51(1):41-3. doi: 10.5414/cpp51041.
5
1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.邻萘醌 1,3-氮唑类化合物的合成：芳基取代的咪唑和噁唑及其对结核分枝杆菌的高效活性。
Bioorg Med Chem. 2012 Nov 1;20(21):6482-8. doi: 10.1016/j.bmc.2012.08.041. Epub 2012 Aug 31.
6
Sequences in the HSP90 promoter form G-quadruplex structures with selectivity for disubstituted phenyl bis-oxazole derivatives.HSP90 启动子序列形成 G-四链体结构，对取代的苯基双恶唑衍生物具有选择性。
Bioorg Med Chem Lett. 2012 Sep 15;22(18):5930-5. doi: 10.1016/j.bmcl.2012.07.065. Epub 2012 Jul 23.
7
Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: dual inhibitors of EGFR and Src protein tyrosine kinases.新型恶唑并[4,5-g]喹唑啉-2(1H)-酮：EGFR 和Src 蛋白酪氨酸激酶的双重抑制剂。
Eur J Med Chem. 2012 Sep;55:39-48. doi: 10.1016/j.ejmech.2012.06.055. Epub 2012 Jul 7.
8
Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.含异噁唑、噁唑和噁二唑的双芳基脲类二酰基甘油酰基转移酶 1 抑制剂的杂芳基类似物的合成与生物评价。
Eur J Med Chem. 2012 Aug;54:324-42. doi: 10.1016/j.ejmech.2012.05.016. Epub 2012 May 22.
9
Synthesis and evaluation of new β-carboline-3-(4-benzylidene)-4H-oxazol-5-one derivatives as antitumor agents.新型β-咔啉-3-(4-亚苄基)-4H-噁唑-5-酮衍生物的合成与抗肿瘤活性评价。
Molecules. 2012 May 21;17(5):6100-13. doi: 10.3390/molecules17056100.
10
Discovery of oxazole-based PDE4 inhibitors with picomolar potency.发现具有皮摩尔效力的基于噁唑的 PDE4 抑制剂。
Bioorg Med Chem Lett. 2012 Apr 1;22(7):2594-7. doi: 10.1016/j.bmcl.2012.01.115. Epub 2012 Feb 14.